Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.
about
Strategy vaccination against Hepatitis B in ChinaThe weight of obesity on the human immune response to vaccinationHBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measuresEvaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study.Comparing Anti-hepatitis B Antibody Level in Iranian Obese or Overweight with Non-obese CasesSeroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.Hepatitis B vaccination among a national sample of gay and bisexual men.Is obesity a risk factor for vaccine non-responsiveness?Immunogenicity of Twinrix in older adults: a critical analysis.Polio vaccines and the cessation of vaccination.Rate of acquired immunity in dental students after hepatitis B vaccinationEffect of age and frequency of injections on immune response to hepatitis B vaccination in drug usersVaccines for women age 50 and older.Sleep and antibody response to hepatitis B vaccination.Serologic control against hepatitis B virus among dental students of the University of Granada, Spain.Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitusOptimal vaccination program for healthy adults in China.Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy.Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac childrenImmune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature.Hepatitis B infection in microbiology laboratory workers: prevalence, vaccination, and immunity status.Suitable hepatitis B vaccine for adult immunization in China.Factors influencing immunologic response to hepatitis B vaccine in adultsAntibody to Hepatitis B Surface Antigen in Vaccinated Health Care Workers.The burden of obesity on infectious disease.Hepatitis B in health care workers: Indian scenario.The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.Obesity: impact of infections and response to vaccines.DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.Response to hepatitis B vaccination in patients with liver cirrhosis.Hepatitis B virus vaccination-related seroprevalence among health-care personnel in a Japanese tertiary medical center.Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States.Severe necrotizing pancreatitis following combined hepatitis A and B vaccination.Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.Cost-effectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel.Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010.Background paper to the revised recommendation for hepatitis B vaccination of persons at particular risk and for hepatitis B postexposure prophylaxis in Germany.
P2860
Q28081068-1C2BEDBA-4624-420A-8430-3EAB539EE8EAQ28088540-B54180D6-79F7-418A-A680-94889F0E47E2Q28388849-33BBD66D-8ACA-4CAA-B3AE-3074E5DDCC58Q33303908-BC688748-697F-4CB2-9B01-83315E562BB0Q33566391-A8487AE5-4A61-40F1-B788-76EB590C242DQ34271615-34D99F05-AB68-41D0-AA71-87BE217ED318Q34329062-26F140A7-63E5-415A-98A3-A36C56DB59FBQ34468786-E066058B-407B-4A6E-8111-B087FD17E564Q35070512-CC53F82E-D8AB-4E8C-931B-870973703797Q35193521-BA172544-30FD-40FC-8C0E-0C5C96CCC5D3Q35193552-58F34AE0-BCC5-47FE-9799-1EB5A2EBDC4DQ35224697-46998604-CC4C-4AD5-88AE-768BE9C9AE4EQ35634215-136B3B05-A5D3-49AC-8804-C04B6CD1A9BEQ35895981-59AF9FEA-624E-4BF2-BEB3-B1A7A072225BQ36097807-9A89083E-2017-4580-B6A7-377A30439DC3Q36139577-AEDC8A2C-912C-49A1-829E-C38AA9CFE007Q36177138-D491102B-7ECD-4E19-8053-490ED175BC7DQ36229312-831E2C95-E8B2-4191-8A77-E729FD776A17Q36256281-3D247FAD-AE83-4D65-B8EA-648AFCCF16DDQ36329025-85A388D3-451A-4708-8626-0134B41BEA52Q36357451-ED2472F4-CA95-4985-9DFD-7861D1ECA9B8Q36426868-1DA345E6-F1AE-41BD-9AD6-1ACD36635D1BQ36486399-D321BCDB-13FB-45C1-9567-C5F804CC9EF1Q36501783-B3E87E1D-A9F8-4493-B7D5-A6C2D5194558Q37023727-7ACDF0F3-D9D8-4BED-BABD-2E80CC837661Q37280298-24AC6081-F045-4FF6-A6FD-F3AE0C00B591Q37815355-97AE08DD-B070-4E31-9CF6-E8B129E34AEEQ37936831-8C0D19F3-0E9C-48CB-9F31-53814CFD6364Q38675773-DFCD35EE-1185-4C72-8E4E-4F1590943582Q38683577-DC6EBF9A-1141-489D-8A87-08D691D96460Q39047929-1F9F2A6D-504F-4F5D-9C83-1D82F60268DFQ39971560-B83171DD-814B-482B-B6A0-BE0831548079Q40047095-2A7B67C1-CA64-4257-AAD9-4DA6528491B6Q40771672-D901E929-D6DD-47AA-899B-8BD42E51D355Q40902759-4171A594-96A9-44CC-9F53-A132D737FF18Q42132139-B4F98992-A5F9-497B-A376-F2B243B55398Q42205390-9FF74987-492D-4315-9C22-0AC2FC954217Q42211174-D2FE668E-E57B-4007-B9AE-6C2A87191148Q42235498-A46CD68B-44A2-4025-A8B8-EFBCF6D79200Q42242530-76B836F2-2019-43F4-98D7-7F6AA3CBBC0A
P2860
Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@en
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@nl
type
label
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@en
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@nl
prefLabel
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@en
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@nl
P2093
P1476
Immunogenicity of hepatitis B ...... f hepatitis B virus infection.
@en
P2093
P356
10.1016/S0749-3797(98)00003-8
P577
1998-07-01T00:00:00Z